Follow us for updates
© 2022 reportr.world
Read the Story →

U.S. Approves COVID-19 Vaccines for Youngest Kids

For children aged five and younger.
by Agence France Presse
Jun 19, 2022
Photo/s: NTF Against COVID-19/Handout
Shares

WASHINGTON --- U.S. health authorities on Saturday cleared the Pfizer and Moderna COVID-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.

The United States thus became the first country to approve use of the so-called mRNA vaccines for children as young as six months.

The U.S. Food and Drug Administration (FDA) had on Friday authorized their emergency use for young children -- who previously had to be at least five to receive the vaccine.

READ: Why Experts Think We'll Need to Vaccinate Children Against COVID

But the vaccines required further clearance from the U.S. Centers for Disease Control and Prevention (CDC), the country's leading public health agency -- and they received that on Saturday.

"We know millions of parents and caregivers are eager to get their young children vaccinated, and with today's decision, they can," CDC Director Rochelle Walensky said in a statement Saturday.

ADVERTISEMENT - CONTINUE READING BELOW ↓

Once the green light was received from the FDA, the U.S. government began distributing millions of doses of the vaccine across the country.

Biden promised that parents could begin scheduling appointments as early as next week to have their young children vaccinated at hospitals, clinics, pharmacies and doctor's offices.

In a statement Saturday, he touted the vaccines as "safe (and) highly effective," and said that "for parents all over the country, this is a day of relief and celebration."

In coming weeks, with more and more doses shipped out, "every parent who wants a vaccine will be able to get one," he said.

The Moderna vaccine, administered in two doses a month apart, will be available to children aged six months to five years in reduced doses of 25 micrograms (half the amount given children aged six to 11, and a quarter the dose for those 12 and older).

The Pfizer-BioNTech vaccine is now authorized for children aged six months to four years, and will be given in doses of three micrograms per injection -- one-tenth the adult dosage.

ADVERTISEMENT - CONTINUE READING BELOW ↓
Recommended Videos

The difference, however, is that children will receive three shots -- the first two three weeks apart, followed by a third eight weeks later.

So, children receiving it will not have full protection for the first few months.

Its side effects, however, have appeared less serious in drug trials than those of the Moderna vaccine.

About a quarter of young children receiving Moderna have developed fevers, particularly after the second dose -- but they generally lasted no more than a day.

About 20 million U.S. children are now eligible, by age, for the new vaccines.

While children have generally proved less vulnerable to COVID-19, some 480 in the U.S. in this age group have died of the virus.

So-called long COVID is also a concern, as is multisystem inflammatory syndrome, a rare but serious post-viral condition.

Pfizer has said it hopes to apply in early July to the European Medicines Agency for authorization to provide its vaccines to children in this youngest age group.

ADVERTISEMENT - CONTINUE READING BELOW ↓

ALSO READ: 

Made by the Devil? That and Many Other Vaccine Myths, Busted

COVID Vaccination of Kids 5-11 Starts, Here's What You Need to Know

Reportr is now on Quento. Download the app or visit the Quento website for more articles and videos from Reportr and your favorite websites.

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.